{"title":"Introduction to a Compendium on Regenerative Cardiology.","authors":"Roberto Bolli, Joshua Hare","doi":"10.1161/CIRCRESAHA.118.313576","DOIUrl":null,"url":null,"abstract":"The field of regenerative cardiology continues to evolve rapidly, requiring frequent updates. The purpose of this compendium is to provide our readers with the most recent concepts pertaining to the use of cell-based strategies for the treatment of heart disease both at the preclinical and clinical levels. The focus is on adult stem cells because embryonic stem cells (or their derivatives) are unlikely to find clinical application or to offer significant advantages compared with induced pluripotent stem cells and adult stem cells.\n\nIt is traditional for compendia published in Circulation Research to start with an Overview in which the Guest Editor(s) outlines the scope and significance of each article. In this case, we could not think of a better author to write the Overview than Dr Eugene Braunwald—the father of modern cardiology. His superb article distils the salient concepts and emerging paradigms in the burgeoning field of cell-based therapies and reparative cardiology and places them in the broader context of cardiovascular medicine.\n\nThe superb synthesis by Dr Braunwald is followed by a series of Reviews and a Viewpoint that address salient facets of the field, including the basic biology of new myocyte formation and cell-based therapies, paracrine mechanisms, the role of extracellular vesicles, novel techniques, such as genome editing and RNA-based therapies, bioengineering approaches, and finally, clinical trials of cell therapy in patients with cardiovascular disease. Although induced pluripotent stem cells may not find immediate clinical application as a therapy for cardiovascular disease (further work may be required to overcome technical and logistical issues), they offer great promise as a model for investigating inherited arrhythmia syndromes and testing antiarrhythmic strategies, as pointed out by Garg et al.1 Besides cell-based strategies, the use of noncoding RNAs has emerged as a potential therapeutic approach for various cardiovascular diseases, one that does …","PeriodicalId":16,"journal":{"name":"ACS Energy Letters ","volume":" ","pages":"129-131"},"PeriodicalIF":19.3000,"publicationDate":"2018-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1161/CIRCRESAHA.118.313576","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Energy Letters ","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1161/CIRCRESAHA.118.313576","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 1
Abstract
The field of regenerative cardiology continues to evolve rapidly, requiring frequent updates. The purpose of this compendium is to provide our readers with the most recent concepts pertaining to the use of cell-based strategies for the treatment of heart disease both at the preclinical and clinical levels. The focus is on adult stem cells because embryonic stem cells (or their derivatives) are unlikely to find clinical application or to offer significant advantages compared with induced pluripotent stem cells and adult stem cells.
It is traditional for compendia published in Circulation Research to start with an Overview in which the Guest Editor(s) outlines the scope and significance of each article. In this case, we could not think of a better author to write the Overview than Dr Eugene Braunwald—the father of modern cardiology. His superb article distils the salient concepts and emerging paradigms in the burgeoning field of cell-based therapies and reparative cardiology and places them in the broader context of cardiovascular medicine.
The superb synthesis by Dr Braunwald is followed by a series of Reviews and a Viewpoint that address salient facets of the field, including the basic biology of new myocyte formation and cell-based therapies, paracrine mechanisms, the role of extracellular vesicles, novel techniques, such as genome editing and RNA-based therapies, bioengineering approaches, and finally, clinical trials of cell therapy in patients with cardiovascular disease. Although induced pluripotent stem cells may not find immediate clinical application as a therapy for cardiovascular disease (further work may be required to overcome technical and logistical issues), they offer great promise as a model for investigating inherited arrhythmia syndromes and testing antiarrhythmic strategies, as pointed out by Garg et al.1 Besides cell-based strategies, the use of noncoding RNAs has emerged as a potential therapeutic approach for various cardiovascular diseases, one that does …
ACS Energy Letters Energy-Renewable Energy, Sustainability and the Environment
CiteScore
31.20
自引率
5.00%
发文量
469
审稿时长
1 months
期刊介绍:
ACS Energy Letters is a monthly journal that publishes papers reporting new scientific advances in energy research. The journal focuses on topics that are of interest to scientists working in the fundamental and applied sciences. Rapid publication is a central criterion for acceptance, and the journal is known for its quick publication times, with an average of 4-6 weeks from submission to web publication in As Soon As Publishable format.
ACS Energy Letters is ranked as the number one journal in the Web of Science Electrochemistry category. It also ranks within the top 10 journals for Physical Chemistry, Energy & Fuels, and Nanoscience & Nanotechnology.
The journal offers several types of articles, including Letters, Energy Express, Perspectives, Reviews, Editorials, Viewpoints and Energy Focus. Additionally, authors have the option to submit videos that summarize or support the information presented in a Perspective or Review article, which can be highlighted on the journal's website. ACS Energy Letters is abstracted and indexed in Chemical Abstracts Service/SciFinder, EBSCO-summon, PubMed, Web of Science, Scopus and Portico.